Cellebrite DI (CLBT) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cellebrite DI reported a remarkable third-quarter 2024, achieving a milestone with $106.9 million in revenue, a 27% increase from the previous year driven by subscription growth. The company’s ARR rose to $370.8 million, and they showcased a strong adjusted EBITDA of $31.3 million. This robust performance has led Cellebrite to raise its 2024 revenue and adjusted EBITDA outlook, reflecting positive investor sentiment and market traction.
For further insights into CLBT stock, check out TipRanks’ Stock Analysis page.